Barcelona, Spain

Manel Raga

This inventor holds 1 USPTO granted patent. Top assignees: Ferrer Internacional, S.a., Fundacion Centrol Nacional De Investigaciones Cardiovasculares Carlos III. Active years: 2014.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manel Raga: Innovator in Cardiovascular Health

Introduction

Manel Raga is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of cardiovascular health through his innovative inventions. His work focuses on developing solutions that can help prevent cardiovascular diseases, particularly in high-risk populations.

Latest Patents

Manel Raga holds a patent for a capsule designed for the prevention of cardiovascular diseases. This invention comprises coated tablets of acetylsalicylic acid, coated tablets of simvastatin or pravastatin, and coated tablets of lisinopril, ramipril, or perindopril. The capsules are intended for use in high-risk populations to help mitigate the risk of cardiovascular diseases. He has 1 patent to his name.

Career Highlights

Throughout his career, Manel Raga has worked with prominent organizations such as Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos III and Ferrer Internacional, S.A. His experience in these institutions has allowed him to collaborate with leading experts in the field of cardiovascular research.

Collaborations

Some of Manel Raga's notable coworkers include Marta Guerrero and Pablo Martin. Their collaborative efforts have contributed to advancements in cardiovascular health and research.

Conclusion

Manel Raga's innovative work in developing a capsule for the prevention of cardiovascular diseases highlights his commitment to improving health outcomes for high-risk populations. His contributions to the field are significant and demonstrate the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…